| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 3.288 | 128.109 | 457.120 | 736.919 | 879.457 | 997.837 | 1.077.198 |
| Total Income - EUR | - | - | - | 3.290 | 128.109 | 457.134 | 736.920 | 879.458 | 997.838 | 1.077.198 |
| Total Expenses - EUR | - | - | - | 10.392 | 116.986 | 417.788 | 617.898 | 752.921 | 806.169 | 924.788 |
| Gross Profit/Loss - EUR | - | - | - | -7.102 | 11.122 | 39.346 | 119.022 | 126.537 | 191.669 | 152.410 |
| Net Profit/Loss - EUR | - | - | - | -7.205 | 9.841 | 34.770 | 108.225 | 117.718 | 169.962 | 128.479 |
| Employees | - | - | - | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Biodaphne Health S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 552 | 74 | 27 | 3.899 | 3.073 | 6.645 | 85.992 |
| Current Assets | - | - | - | 18.941 | 51.489 | 98.821 | 780.323 | 422.106 | 602.343 | 815.323 |
| Inventories | - | - | - | 15.141 | 31.900 | 72.066 | 608.337 | 322.002 | 396.189 | 530.764 |
| Receivables | - | - | - | 3.677 | 17.614 | 20.787 | 142.413 | 103.508 | 187.242 | 272.672 |
| Cash | - | - | - | 122 | 1.974 | 5.968 | 29.573 | -3.404 | 18.912 | 11.886 |
| Shareholders Funds | - | - | - | -2.917 | 6.981 | 41.619 | 113.873 | 123.383 | 247.537 | 341.243 |
| Social Capital | - | - | - | 4.288 | 4.205 | 4.125 | 4.034 | 4.046 | 4.043 | 4.021 |
| Debts | - | - | - | 22.410 | 44.582 | 57.229 | 670.349 | 301.796 | 361.451 | 564.851 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4645 - 4645" | |||||||||
| CAEN Financial Year |
4645
|
|||||||||
Comments - Biodaphne Health S.r.l.